COMMUNIQUÉS West-GlobeNewswire

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
01/05/2024
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 million Increasing 2024 revenue guidance to $83-85 million, previously $79-81 million [...]
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)
01/05/2024
Subretinal injection of ATSN-201 was well tolerated in all patients in the first cohort with extensive resolution of schisis observed in two patients Provides evidence that AAV.SPR spreads laterally outside of [...]
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
01/05/2024
BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Altimmune to Participate at Two Upcoming Conferences
01/05/2024
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present on [...]
VitalHub Announces Strategic Leadership Appointments to Drive Continued Growth and Operational Excellence
01/05/2024
TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) is pleased to announce significant organizational changes to further strengthen its leadership team as it [...]
Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board
01/05/2024
AMSTERDAM and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Professor Sandra [...]
Janssen to adopt Johnson & Johnson brand as the Company celebrates 100 years of operating in the UK
01/05/2024
Johnson & Johnson marks new era in the UK with updated visual identity High Wycombe, UK, May 01, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced it is updating its brand and uniting both its two [...]
Intermountain Health Opens First-of-Its-Kind in the Region Spanish Speaking Kidney Transplant Clinic
01/05/2024
SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Intermountain Health has opened the first clinic of its kind in the Intermountain West that is designed specifically to support Spanish-speaking patients undergoing [...]
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
30/04/2024
Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024 FREMONT, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions [...]
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
30/04/2024
GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility. “In light of [...]
R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference
30/04/2024
MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, [...]
Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center
30/04/2024
DALLAS, April 30, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
30/04/2024
Conference call to be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held tomorrow [...]
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
30/04/2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
30/04/2024
Visit the Codman Specialty Surgical booth to learn how the CereLink ICP Monitoring System provides patients with uncompromised advanced continuous ICP monitoring. PRINCETON, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- [...]
Clearmind Applies to Cease Being a Reporting Issuer in Canada
30/04/2024
Vancouver, Canada, April 30, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) (" Clearmind " or the “ Company ”), a clinical- stage biotech company focused on discovery and development [...]
CooperCompanies Announces Release Date for Second Quarter 2024
30/04/2024
SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET. Following the release, [...]
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
30/04/2024
- Company to provide update on exciting new commercial agreement, as well as Phase 2 clinical trial in Spine and preclinical development program in Obesity - MELVILLE, N.Y., April 30, 2024 (GLOBE NEWSWIRE) -- [...]
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
30/04/2024
FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare [...]

Pages